Hepatitis B
612
29
40
409
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
140 trials with published results (23%)
Research Maturity
409 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.2%
38 terminated out of 612 trials
91.5%
+5.0% vs benchmark
38%
233 trials in Phase 3/4
34%
140 of 409 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 409 completed trials
Clinical Trials (612)
A Real-world Study: Analysis of the Efficacy of Antiviral Therapy in CHB Patients Over 30 Years Old, HBV DNA Positive and ALT Normal
Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV
Evaluation of Patients With Liver Disease
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
Real World Assessment of People Living With Chronic Hepatitis B in Australia
Hep Mec Cohort in Zambia
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
The COMBAT HBV Feasibility Trial
Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
HepB mAb19 in Individuals With Chronic Hepatitis B Infection
HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B